Replies to post #328067 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

You might read a bit a closer in that first quote.

Concerns are inevitably greatest when the change is made late and has an important effect on outcome. In theory, if such changes are unequivocally made blindly (e.g., because of data from other trials or careful reconsideration) they should not pose problems, but the assurance of blinding can be hard to provide. For obvious reasons, changes made with data in hand (but purportedly still blinded) pose the greatest difficulties and are hard to support

NWBO has a ton of data on the trial despite being purportedly blinded. Both the bloodwork and shipping records effectively break the blind.

[biosectinvestor]

It’s an adaptive trial, there can only be speculation, and based upon old allegations, that the FDA acted badly. The shorts love to feed fears of longs that the process is arbitrary, that the company is shady, and that everyone is acting badly in some way that will ultimately backfire and lead to a disastrous result. That’s their job.